Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MD05 for Alveolar Bone Regeneration in Periodontal Surgery
NCT00519155Phase 2Unknown
- Sponsor
- Scil Technology
- Start
- Jul 2007
- Primary completion
- Oct 2008
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of MD05 in Alveolar bone loss and periodontitis (2 arms), sponsored by Scil Technology. Primary endpoint: Evidence of regeneration of alveolar bone at 15 months. Status: unknown.
02
Drugs
MD05
03
Conditions
Alveolar bone lossperiodontitis
Beyond the preview
Go deeper on NCT00519155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519155.